Pharmadrug Inc. (CSE: PHRX)
Canada
· Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Sep 26, 2024, 2:14 PM EDT
Pharmadrug Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -13.29 | -13.2 | -8.88 | -5.63 | -5.15 | -6.29 | Upgrade
|
| Depreciation & Amortization | 0.05 | 0.03 | 0.02 | 0.02 | 1.3 | 0.78 | Upgrade
|
| Other Amortization | 0.01 | 0.04 | 0.03 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 10.14 | 10.14 | - | - | 0.47 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.09 | 0.05 | 0.61 | 0.72 | -2.53 | 1.14 | Upgrade
|
| Stock-Based Compensation | 1.79 | 1.74 | 0.34 | 0.6 | 0.77 | 0.53 | Upgrade
|
| Other Operating Activities | 0.26 | 0.23 | 5.8 | 1.46 | 3.75 | -0.06 | Upgrade
|
| Change in Accounts Receivable | -0.05 | 0 | -0.06 | 0.06 | -0.14 | -0.12 | Upgrade
|
| Change in Inventory | - | - | 0.07 | 0 | 0.08 | -0.1 | Upgrade
|
| Change in Accounts Payable | -0.08 | 0.35 | 0.57 | -0.18 | -0.09 | 0.59 | Upgrade
|
| Change in Income Taxes | - | - | - | - | -0.12 | -0.11 | Upgrade
|
| Change in Other Net Operating Assets | -0.12 | -0.06 | 0.1 | -0.02 | 0.02 | 0.12 | Upgrade
|
| Operating Cash Flow | -1.2 | -0.67 | -2.26 | -4.13 | -1.8 | -2.34 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.02 | -0.01 | Upgrade
|
| Cash Acquisitions | 0.74 | 0.74 | - | 0.31 | 2.18 | -7.32 | Upgrade
|
| Divestitures | - | - | -0.01 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.01 | Upgrade
|
| Investment in Securities | 0.01 | 0.25 | 0.09 | 1.21 | 1.62 | - | Upgrade
|
| Other Investing Activities | - | - | -0 | -0.04 | - | 0.02 | Upgrade
|
| Investing Cash Flow | 0.75 | 1 | 0.08 | 1.48 | 3.78 | -7.32 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.25 | 3.6 | Upgrade
|
| Long-Term Debt Issued | - | 0.1 | 0.65 | - | - | - | Upgrade
|
| Total Debt Issued | - | 0.1 | 0.65 | - | 0.25 | 3.6 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -1.89 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.1 | -0.05 | - | -0.3 | -0.02 | Upgrade
|
| Total Debt Repaid | - | -0.1 | -0.05 | - | -2.19 | -0.02 | Upgrade
|
| Net Debt Issued (Repaid) | - | 0 | 0.6 | - | -1.94 | 3.58 | Upgrade
|
| Issuance of Common Stock | 0.33 | - | 0.27 | 0.95 | 1.57 | 6.53 | Upgrade
|
| Other Financing Activities | 0.25 | 0.22 | -0.03 | -0.18 | 0.51 | -0.6 | Upgrade
|
| Financing Cash Flow | 0.57 | 0.23 | 0.84 | 0.78 | 0.13 | 9.51 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | 0.39 | 0.69 | -0.05 | 0.07 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - | Upgrade
|
| Net Cash Flow | 0.13 | 0.55 | -0.95 | -1.18 | 2.06 | -0.08 | Upgrade
|
| Free Cash Flow | -1.2 | -0.67 | -2.26 | -4.13 | -1.82 | -2.35 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -58906.35% | -266.35% | -384.84% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.05 | -0.09 | -0.09 | -0.23 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.08 | 0.04 | 0.11 | 0.06 | 0.07 | Upgrade
|
| Levered Free Cash Flow | 1.35 | 1.71 | -1.59 | -1.26 | -1.34 | -1.23 | Upgrade
|
| Unlevered Free Cash Flow | 1.57 | 1.88 | -1.48 | -1.23 | -1.12 | -0.93 | Upgrade
|
| Change in Net Working Capital | -0.57 | -0.96 | 0.38 | 0.14 | 0.7 | -0.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.